Fecal microbiota transplantation in treating Clostridium difficile infection

@article{Brown2014FecalMT,
  title={Fecal microbiota transplantation in treating Clostridium difficile infection},
  author={William R. Brown},
  journal={Journal of Digestive Diseases},
  year={2014},
  volume={15}
}
Clostridium difficile infection (CDI) is an increasingly common and severe international health problem. Customary treatment of this infection, usually with antibiotics, is often ineffective and its recurrence is common. In recent years the treatment of recurrent or refractory CDI by the transfer of stool from an uninfected person, so called fecal “microbiota transplantation” has become recognized as effective and generally safe. The effectiveness of this novel treatment is incompletely defined… 
Fecal Microbiota Transplantation for Ulcerative Colitis: FoMenTing Change?
  • F. Martins
  • Medicine
    Digestive Diseases and Sciences
  • 2016
TLDR
The novel observation that FMT is beneficial in a well-established mouse model of chemically induced colitis termed the dextran sodium sulfate (DSS) model is reported, with little evidence of an inflammatory infiltrate in the intestines after FMT was stopped.
Clostridium difficile: Current Status andTreatment Perspectives
TLDR
Fecal microbiota transplants (FMT) is a procedure in which fecal matter is collected from a tested donor, mixed with a saline or other solution, strained, and placed in a patient by colonoscopy, endoscope, sigmoidscopy or enema, with its efficacy being proven constantly study after study.
A Retrospective Comparison of Fecal Microbial Transplantation Methods for Recurrent Clostridium Difficile Infection.
TLDR
Lower GI tract FMT is a safe and effective treatment for refractory and recurrent CDI, and yields quicker results than upper GI tractfecal microbiota transplantation.
Clostridium Difficile Infection: Risk Factors, Diagnosis and Management
  • C. Surawicz
  • Medicine
    Current Treatment Options in Gastroenterology
  • 2015
TLDR
Treatment should be stratified by severity of disease, with metronidazole use for mild disease cases and vancomycin for severe disease, and in patients with multiple recurrences, fecal microbiota transplant has a high rate of success.
Novel Indications for Fecal Microbial Transplantation: Update and Review of the Literature
TLDR
FMT was found to be possibly effective in various diseases, mostly associated with enteric dysbiosis or with immune dysfunction, and shows promise to provide another effective tool in the therapeutic armament of the practicing physician.
A combination of the probiotic and prebiotic product can prevent the germination of Clostridium difficile spores and infection.
TLDR
The combination of xylitol with L. plantarum Inducia suppresses the germination of spores and outgrowth into vegetative toxin producing cells of C. difficile and reduces the colonization of gut with the pathogen.
Cutting Edge: Probiotics and Fecal Microbiota Transplantation in Immunomodulation
TLDR
The aim of this review was to follow through the recent literature survey on immunomodulatory effects and mechanisms of probiotics and FMT and also efficacy and safety of probiotic and F MT in clinical trials and applications.
Immunomodulatory effects of probiotics: Can they be used to treat allergies and autoimmune diseases?
TLDR
The cross-talk between probiotics and the gastrointestinal immune system, and their effects in relation to inflammatory bowel disease, multiple sclerosis, allergies and atopic dermatitis are described.
Early intervention with faecal microbiota transplantation: an effective means to improve growth performance and the intestinal development of suckling piglets.
  • C. Cheng, H. Wei, +4 authors J. Peng
  • Biology, Medicine
    Animal : an international journal of animal bioscience
  • 2019
TLDR
Findings indicate that early intervention with maternal faecal microbiota improves growth performance, decreases intestinal permeability, stimulates sIgA secretion, and modulates gut microbiota composition and metabolism in suckling piglets.
A curated C. difficile strain 630 metabolic network: prediction of essential targets and inhibitors
TLDR
i MLTC806cdf is the most complete and accurate metabolic reconstruction of a gram-positive anaerobic bacteria to date and is used to predict essential genes as potential new therapeutic targets in the fight against Clostridium difficile infections.
...
1
2
...

References

SHOWING 1-10 OF 31 REFERENCES
Fecal microbiota transplantation: the state of the art
TLDR
The pathophysiological basis and the clinical indications of gut microbiota transplantation are reported that, in light of its low cost, and proven efficacy and safety, is likely to become part of the management guidelines of difficult cases of CDI in the near future.
Fecal microbiota transplantation in the treatment of Clostridium difficile infections.
TLDR
Fecal microbiota transplantation has been shown to be efficacious for patients with multiply recurrent Clostridium difficile infections (reported cure rates of 90%), with an excellent short-term safety profile, and has been included in the American College of Gastroenterology treatment guidelines for this troublesome disease.
Fecal Microbiota Transplantation for Refractory Clostridium difficile Colitis in Solid Organ Transplant Recipients
  • R. Friedman-Moraco, A. Mehta, G. Lyon, C. Kraft
  • Medicine
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
  • 2014
TLDR
Two solid organ transplant recipients are described, one lung and one renal, in this case report that both had resolution of their diarrhea caused by C. difficile after FMT.
Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection.
TLDR
Effectiveness varied by route of instillation, relationship to stool donor, volume of IMT given, and treatment before infusion, but findings can guide physicians interested in implementing the procedure until better designed studies are conducted to confirm best practices.
Treatment of relapsing Clostridium difficile infection using fecal microbiota transplantation
TLDR
FMT is a cheap, easily available, effective therapy for recurrent CDI; it can be safely performed in a community hospital setting with similar results.
Efficacy of combined jejunal and colonic fecal microbiota transplantation for recurrent Clostridium difficile Infection.
  • S. Dutta, M. Girotra, +7 authors W. F. Fricke
  • Medicine
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2014
TLDR
FMT was associated with marked changes in the composition of fecal microbiota in 2 patients with RCDI, and increased microbial diversity, increasing proportions of Lachnospiraceae (phylum Firmicutes) and reducing proportions of Enterobacteriaceae.
Microbiota Dynamics in Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
TLDR
Overall microbiota compositions in post-FMT patients, specifically abundances of the above-mentioned Firmicutes, continued to change for at least 16 weeks after FMT, suggesting that full microbiota recovery from RCDI may take much longer than expected based on the disappearance of diarrheal symptoms immediately after F MT.
From stool transplants to next-generation microbiota therapeutics.
TLDR
2 pathways in the development of this new therapeutic class of microbiota therapeutics are discussed: whole microbial communities separated from donor stool and an assembly of specific fecal microorganisms grown in vitro.
Fecal microbiota transplantation: a practical update for the infectious disease specialist.
TLDR
Step-by-step guidance to infectious disease specialists on how to navigate the regulatory requirements and successfully obtain an IND before they can begin to use FMT as part of their clinical practice is provided.
Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection.
TLDR
Fecal transplantation through colonoscopy seems to be an effective treatment for recurrentCDI and also for recurrent CDI caused by the virulent C difficile 027 strain.
...
1
2
3
4
...